Sparber Lauren S, Lau Christine Sm, Vialet Tanya S, Chamberlain Ronald S
Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA.
Saint George's University School of Medicine, Grenada, West Indies.
J Pain Res. 2017 Jul 5;10:1555-1560. doi: 10.2147/JPR.S132836. eCollection 2017.
Inguinal and umbilical hernia repairs are among the most common surgical procedures performed in the US. Optimal perioperative pain control regimens remain challenging and opioid analgesics are commonly used. Preoperative nonsteroidal anti-inflammatory drug (NSAID) administration has been shown to reduce postoperative narcotic requirements. This study sought to evaluate the efficacy of perioperative intravenous (IV) ibuprofen on postoperative pain level and narcotic use in patients undergoing open or laparoscopic inguinal and/or umbilical hernia repair.
A single center, randomized, double-blind placebo-controlled trial involving patients ≥18 years undergoing inguinal and/or umbilical hernia repair was performed. Patients were randomized to receive 800 mg of IV ibuprofen or placebo preoperatively. Outcomes assessed included postoperative pain medication required and visual analog scale (VAS) pain scores.
Forty-eight adult male patients underwent inguinal and/or umbilical hernia repair. Patients receiving IV ibuprofen used more oxycodone/acetaminophen (32% vs 13%) and IV hydromorphone (12% vs 8.7%), and fewer combinations of pain medications (44% vs 65.2%) in the first two postoperative hours compared to placebo (=0.556). The IV ibuprofen group had more patients pain free (28% vs 8.7%, =0.087) and lower VAS scores (3.08±2.14 vs 3.95±1.54, =0.134) at 2 hours postoperatively, compared to the placebo group, however, this was not statistically significant. Similar pain levels at 1, 3, and 7 days, postoperative and similar use of rescue medications in both groups were observed.
Preoperative administration of IV ibuprofen did not significantly reduce postoperative pain among patients undergoing elective hernia repair. Considerable variability in postoperative narcotic analgesic requirement was noted, and larger scale studies are needed to better understand the narcotic analgesic requirements associated with IV ibuprofen in inguinal/umbilical hernia repair patients.
腹股沟疝和脐疝修补术是美国最常见的外科手术之一。优化围手术期疼痛控制方案仍然具有挑战性,阿片类镇痛药被广泛使用。术前给予非甾体抗炎药(NSAID)已被证明可减少术后对麻醉剂的需求。本研究旨在评估围手术期静脉注射布洛芬对接受开放或腹腔镜腹股沟疝和/或脐疝修补术患者术后疼痛水平和麻醉剂使用的疗效。
进行了一项单中心、随机、双盲、安慰剂对照试验,纳入年龄≥18岁接受腹股沟疝和/或脐疝修补术的患者。患者被随机分为术前接受800mg静脉注射布洛芬或安慰剂。评估的结果包括术后所需的止痛药物和视觉模拟量表(VAS)疼痛评分。
48例成年男性患者接受了腹股沟疝和/或脐疝修补术。与安慰剂组相比,接受静脉注射布洛芬的患者在术后头两个小时使用更多的羟考酮/对乙酰氨基酚(32%对13%)和静脉注射氢吗啡酮(12%对8.7%),且使用的止痛药物组合更少(44%对65.2%)(P=0.556)。与安慰剂组相比,静脉注射布洛芬组在术后2小时无痛患者更多(28%对8.7%,P=0.087),VAS评分更低(3.08±2.14对3.95±1.54,P=0.134),然而,这在统计学上并不显著。观察到两组术后1、3和7天的疼痛水平相似,且使用急救药物的情况相似。
术前静脉注射布洛芬并不能显著降低择期疝修补术患者的术后疼痛。术后麻醉性镇痛药需求存在相当大的变异性,需要进行更大规模的研究,以更好地了解腹股沟/脐疝修补术患者中与静脉注射布洛芬相关的麻醉性镇痛药需求。